Media ReleaseCOPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE® NHL-2 trial show investigational treatment with epcoritamab in combination with…
VICTORIA, Seychelles, June 5, 2025 /PRNewswire/ -- MEXC IgniteX, the $30 million global CSR initiative and innovation arm of MEXC Ventures,…